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Why is it important to assess indications for red 
blood cell transfusion in premature infants?
Por que é importante analisar fatores associados à indicação de 
transfusões de hemácias em prematuros?
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Performing blood transfusions for premature infants is becoming an 
increasingly discussed and controversial topic. Interestingly, once a procedure 
that was routinely performed without much discussion when a premature 
infant was anemic or had severe blood loss, blood transfusion is now the focus 
of discussions regarding its indications, with conflicting concerns related to the 
harm resulting from excess or inadequate red blood cell transfusion.
Before discussing the risks and benefits of red blood cell transfusion, one must 
remember that anemia is common in the first few months of life in premature 
neonates, mainly due to the blood loss associated with multiple blood drawing 
during the first few weeks of life, during which critically ill premature infants 
require continuous monitoring for their respiratory, cardiovascular, infectious, 
metabolic, and nutritional status. Furthermore, the low rate of erythropoiesis 
associated with erythropoietin deficiency, which is characteristic of the 
initial adaptation to extrauterine life, causes premature neonates to become 
progressively more anemic during their hospitalization in the neonatal intensive 
care unit after the initial clinical stabilization.(1) 
Thus, red blood cell transfusions are frequently necessary in neonatal units 
that care for premature infants. A study by the Brazilian Network on Neonatal 
Research (Rede Brasileira de Pesquisas Neonatais), in which 952 premature 
infants weighing between 400 and 1,499 g born in eight Brazilian university 
neonatal units between 2006 and 2007, showed that 532 infants (56%) received 
at least one blood transfusion. Of these patients, 335 (63%) received more than 
one transfusion during the hospital stay, and the mean number of transfusions 
per newborn ranged from 1.6±1.0 to 5.9±5.2 among the studied centers.(2) 
Another recent assessment of the data from this same research network, which 
included 4,238 premature infants with a mean gestational age of 29.9±2.9 
weeks and weight of 1.084±275 g born in 16 units in eight Brazilian states from 
2009 to 2011, indicated that 2,208 patients (52%) received at least one red 
blood cell transfusion, and the rate varied from 34 to 72% among the centers.(3) 
Such variation among the centers may at least partially be attributed to 
using empiric, rather than evidence-based, guidelines for performing red blood 
cell transfusions, with protocols ranging from restrictive to liberal transfusion 
thresholds according to published international guidelines for indications for 
such transfusions.(4-6)
Restrictive criteria for blood product transfusion take procedure-related 
concerns into account. Traditionally, such concerns are due to the viral, bacterial, 
and prion infections related to the donor, but incidence of such infections has 
been progressively declining.(7) However, there has been a growing concern 
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regarding increased mortality in transfused premature 
infants,(8) partially related to the immunomodulatory 
and proinflammatory effects of transfusions and the 
development of multiple organ failure.(9) 
In this context, the association between necrotizing 
enterocolitis and red blood cell transfusion has been 
reported in the literature.(10,11) One hypothesis is that the 
release of free hemoglobin after red blood cell transfusion 
reduces the production of nitric oxide, a potent mesenteric 
vasodilator.(12,13) Additionally, red blood cell transfusion 
may lead to the activation of T-antigen variants or other 
antigens present on the surface of red blood cells, producing 
antibodies that may cause intravascular hemolysis. Such 
antibodies are also found in donor blood and have been 
frequently identified in children with sepsis and necrotizing 
enterocolitis, although their pathophysiological role in 
these diseases is not well characterized.(14,15) However, this 
association was described in experimental studies, and 
randomized, controlled studies are necessary for more 
robust conclusions. 
In contrast, more liberal red blood cell transfusion 
criteria take into account the possible long-term effects 
of anemia, especially on growth and development, 
due to decreased tissue oxygen delivery. In a study that 
compared the long-term outcomes, premature infants 
were randomized to maintain high or low hemoglobin 
levels during the neonatal period. Neurodevelopment 
was assessed by Bayley II scales and delay was defined 
by mental index score <85 with a corrected age of 18 to 
21 months. Developmental delay was more frequent in 
children who received transfusions under more restrictive 
criteria.(16) Other long-term studies that used psychological 
tests and functional brain imaging for 8- to 15-year-old 
patients favored more restrictive strategies for red blood 
cell transfusion during the neonatal period. One of these 
studies showed that premature infants transfused using 
liberal criteria performed poorly on tests of association, 
verbal fluency, visual memory, and reading compared 
to the infants transfused under restrictive criteria.(17) 
Corroborating these results, another study showed that 
several areas of the brain were smaller, especially the white 
matter and the subcortical nuclei, in the premature infants 
transfused using liberal criteria compared to restrictive 
criteria.(18) However, these studies had a significant loss of 
follow up after the neonatal period, compromising their 
external validity.(19) 
In this context, Freitas and Franceschini bring their 
contribution to this issue of the Revista Brasileira de 
Terapia Intensiva.(20) The authors studied 254 premature 
infants born in one center in Minas Gerais State, Brazil, 
and 100 of these infants (39%) required at least one 
transfusion. A gestational age less than 32 weeks and 
the presence of neonatal sepsis were factors associated 
with transfusions in this group of premature infants. 
Other two studies of the Brazilian Network on Neonatal 
Research also evaluated factors associated to red blood 
cell transfusions in very low birth weight infants. The 
first one, which assessed 952 premature infants weighing 
between 400 and 1,499 g in eight Brazilian university 
neonatal units between 2006 and 2007, indicated that 
the factors related to transfusions, adjusted for the 
birth center, were: late-onset sepsis (OR=2.83, 95% CI 
1.80-4.44), grade III/IV intraventricular hemorrhage 
(OR=9.42, 95% CI 3.32-26.75), resuscitation requiring 
intubation in the delivery room (OR=1.69, 95% CI 
1.02-2.83), umbilical catheter use (OR=2.39, 95% CI 
1.30-4.40), number of days on mechanical ventilation 
(OR=1.09, 95% CI 1.02-1.16), oxygen therapy 
(OR=1.05, 95% CI 1.03-1.07), and parenteral nutrition 
(OR=1.06, 95% CI: 1.03-1.10).(2) The second study 
assessed data from 4,238 premature infants born in 16 
units in eight Brazilian states from 2009 to 2011 and 
showed that the factors associated with transfusions, 
adjusted for the birth center, were: low gestational age 
(OR=1.55; 95% CI 1.14-21.11), presence of apnea 
(OR=1.82; 95% CI 1.42-2.34), pulmonary hemorrhage 
(OR=2.18; 95% CI 1.39-3.43), use of oxygen for 28 
days or more (OR=1.46; 95% CI 1.09-1.96), clinical 
sepsis (OR=3.37; 95% CI 2.63-4.33), necrotizing 
enterocolitis (OR=4.16; 95% CI 2.34-7.34), grade III/
IV intraventricular hemorrhage (OR=1.74; 95% CI 
1.10-2.77), retinopathy of prematurity (OR=1.36; 95% 
CI 1.00-1.86), mechanical ventilation (OR=2.62; 95% 
CI 1.98-3.47), umbilical catheterization (OR=2.03; 
95% CI 1.45-2.285), parenteral nutrition (OR=3.17; 
95% CI 1.84-5.43), vasoactive drugs (OR=1.74; 95% 
CI 1.21-2.50), and length of hospital stay >60 days 
(OR=4.90; 95% CI 3.67-6.54).(3) Therefore, regardless 
of using restrictive or liberal protocols for red blood cell 
transfusion, the studies together show that transfusion 
indications were associated with initial illness severity, 
which was highlighted by the presence of prematurity 
and associated morbidities, and by the prolonged need 
of life support measures such as oxygen, mechanical 
ventilation, central catheters, and parenteral nutrition. 
Furthermore, the diagnosis of late-onset sepsis on preterm 
newborn infants, which indicates their immunological 
immaturity and their unique susceptibility to infra-
structure deficiencies of human and equipment resources 
in Neonatal Intensive Care Units, was associated with 
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clinical instability and the need for support, including 
the need for transfusion of blood products.
Thus, using evidence-based guidelines for red blood 
cell transfusion in premature infants is absolutely 
necessary. The major issue is that the evidence is 
controversial and does not allow for determining 
universal guidelines. Future studies must identify 
factors associated to the need for red blood cell 
transfusion in neonatal intensive care units and attempt 
to minimize these factors as well as phlebotomy losses 
in this susceptible population in order to rationalize the 
indications for such transfusions.
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